|
TPP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.85250000018078E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.81300000012818E-07 |
| Normal-vs-Stage2 |
1.643380E-03 |
| Normal-vs-Stage3 |
9.357400E-03 |
| Normal-vs-Stage4 |
1.271770E-02 |
| Stage1-vs-Stage2 |
5.918000E-01 |
| Stage1-vs-Stage3 |
3.054100E-02 |
| Stage1-vs-Stage4 |
2.131800E-01 |
| Stage2-vs-Stage3 |
8.780500E-02 |
| Stage2-vs-Stage4 |
2.025600E-01 |
| Stage3-vs-Stage4 |
6.306600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.02379999992131E-07 |
| Normal-vs-AfricanAmerican |
3.086100E-02 |
| Normal-vs-Asian |
5.076600E-03 |
| Caucasian-vs-AfricanAmerican |
3.233000E-01 |
| Caucasian-vs-Asian |
5.187000E-01 |
| AfricanAmerican-vs-Asian |
2.553000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.71089999999796E-05 |
| Normal-vs-Female |
4.15180000046256E-07 |
| Male-vs-Female |
1.610190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.737900E-02 |
| Normal-vs-Age(41-60Yrs) |
4.94470000500513E-08 |
| Normal-vs-Age(61-80Yrs) |
3.392800E-04 |
| Normal-vs-Age(81-100Yrs) |
3.577800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.673600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.094000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.474000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.491970E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.236160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.690200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.63439999984116E-07 |
| Normal-vs-Grade 2 |
1.90309999981153E-08 |
| Normal-vs-Grade 3 |
3.360600E-04 |
| Normal-vs-Grade 4 |
2.464400E-01 |
| Grade 1-vs-Grade 2 |
1.692630E-01 |
| Grade 1-vs-Grade 3 |
4.480000E-03 |
| Grade 1-vs-Grade 4 |
3.617700E-03 |
| Grade 2-vs-Grade 3 |
8.455900E-03 |
| Grade 2-vs-Grade 4 |
2.740600E-03 |
| Grade 3-vs-Grade 4 |
1.554990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.78459477698334E-11 |
| Normal-vs-ccB subtype |
1.177610E-02 |
| ccA subtype-vs-ccB subtype |
4.35290000000421E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.13900000004086E-06 |
| Normal-vs-N1 |
2.174600E-01 |
| N0-vs-N1 |
6.298000E-01 |
|
|
